Takeda Joins Lhasa's Effiris Consortium

Effiris delivers state-of-the-art secondary pharmacology models, where each model learns from the in-house confidential data of pharmaceutical

On the route to the future of clinical trials, UCB works with the EFFIRIS consortium to predict the safety profile of medicines including

effiris Effiris: A secondary pharmacology model suite powered by privacy-preserving data sharing · Virtual Screening Effiris facilitates more efficient

effiris Multidisciplinary Digital Pu Journal article Federated Learning in Computational Toxicology: An Industrial Perspective on the Effiris Hackathon Request